SuperworthDianthus Therapeutics market cap DNTH
Share price times shares outstanding: what the whole company sells for, since 2018.
- Today, Oct 23, 2026
- $4.3B
- Highest close in our data
- $6.5B
- Aug 2026
Dianthus Therapeutics is worth $4.3B at the close on Oct 23, 2026, at $76.78 a share.
That is up 305% over the last year and up 1046% over five years.
Its highest close in our data was $6.5B in Aug 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $4.3B | $1.6B | $6.5B | +139% |
| 2025 | $1.8B | $517.9M | $1.9B | +166% |
| 2024 | $673M | $176.8M | $937.3M | +337% |
| 2023 | $154.1M | $28M | $173.4M | +544% |
| 2022 | $23.9M | $22.1M | $274.5M | −91% |
| 2021 | $260.4M | $260.4M | $632.7M | −31% |
| 2020 | $378.7M | $237.1M | $594.2M | −34% |
| 2019 | $570.8M | $202.9M | $621.5M | +202% |
| 2018 | $189M | $189M | $481M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Dianthus Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| DNTHDianthus Therapeutics | $4.3B |
| INDVIndivior Pharmaceuticals | $4.1B |
| ARQTArcutis Biotherapeutics | $3.9B |
| LQDALiquidia | $3.8B |
| OGNOrganon | $3.6B |
| KNSAKiniksa Pharmaceuticals International | $6B |
| LGNDLigand Pharmaceuticals | $6.1B |
| AMRXAmneal Pharmaceuticals | $6.5B |
| NRIXNurix Therapeutics | $2.8B |
| ALKSAlkermes plc. | $7.3B |
| PBHPrestige Consumer Healthcare | $2.3B |
| Peer median | $4B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Dianthus Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.